Surrozen is pioneering therapies that harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. The company develops multi-target antibody therapeutics to improve and restore sight, focusing on addressing the underlying drivers of disease.

Surrozen is pioneering therapies that harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. The company develops multi-target antibody therapeutics to improve and restore sight, focusing on addressing the underlying drivers of disease.